Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ARDX | ALMS |
|---|---|---|
| Price | $3.26 | $6.77 |
| Change today | ▼ 1.51% | ▼ 2.31% |
| Market cap | $841.69M | $876.28M |
| Return, 3 months | -39.4% | -77.7% |
| Return, year to date | -44.1% | -30.6% |
| Return, 1 year | -35.6% | +52.8% |
| P/E (TTM) | -14.2 | -1.6 |
| P/B | 5.6 | 1.9 |
| P/E percentile vs own 5y | 64th | 73rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +23.8% | -37.7% |
| Net profit growth (YoY) | +12.4% | -339.7% |
| Gross margin | 94.4% | – |
| Operating margin | -7.9% | -5,639.1% |
| Net margin | -12.4% | -5,933.5% |
| Return on equity | -38.6% | -93.6% |
| Analyst target vs. price | +312.0% | +335.7% |
| Analyst buy share | 100% | 88% |
| RSI (14) | 30 | 21 |
| 30-day volatility | 28.8% | 247.1% |
| Max drawdown, 1 year | -59.2% | -77.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
